A New Approach for Classifying Fetal Growth Restriction

被引:16
作者
Hutcheon, Jennifer A. [1 ]
Riddell, Corinne A. [2 ,3 ]
Himes, Katherine P. [4 ,5 ]
机构
[1] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada
[2] Univ Calif Berkeley, Div Biostat, Sch Publ Hlth, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Div Epidemiol, Sch Publ Hlth, Berkeley, CA 94720 USA
[4] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Sch Med, Pittsburgh, PA USA
[5] Magee Womens Res Inst, Pittsburgh, PA USA
关键词
Fetal growth; Fetal growth restriction; Small for gestational age birth; Latent class analysis; DIAGNOSTIC-TEST; ACCURACY; ABSENCE; CLASSIFICATION; STANDARDS; MODELS; TESTS;
D O I
10.1097/EDE.0000000000001399
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Fetal growth restriction is commonly defined using small for gestational age (SGA) birth (birthweight < 10th percentile) as a proxy, but this approach is problematic because most SGA infants are small but healthy. In this proof-of-concept study, we sought to develop a new approach for identifying fetal growth restriction at birth that combines information on multiple, imperfect measures of fetal growth restriction in a probabilistic manner. Methods: We combined information on birthweight, placental weight, placental malperfusion lesions, maternal disease, and fetal acidemia using latent profile analysis to classify fetal growth in births at the Royal Victoria Hospital in Montreal, Canada, 2001-2009. We examined the clinical characteristics and health outcomes of infants classified as growth-restricted and nongrowth-restricted by our model, and among the subgroup of growth-restricted infants who had a birthweight >= 10th percentile (i.e., would have been missed by the conventional SGA proxy). Results: Among 26,077 births, 345 (1.3%) were classified as growth-restricted by our latent profile model. Growth-restricted infants were more likely than nongrowth-restricted infants to have an Apgar score <7 (10% vs. 2%), have hypoglycemia at birth (17% vs. 3%), require neonatal intensive care unit admission (59% vs. 6%), die in the perinatal period (3.8% vs. 0.2%), and require an emergency cesarean delivery (42% vs. 15%). Risks remained elevated in growth-restricted infants who were not SGA, suggesting our model identified at-risk infants not detected using the SGA proxy. Conclusions: Latent profile analysis is a promising strategy for classifying growth restriction at birth in fetal growth restriction research.
引用
收藏
页码:860 / 867
页数:8
相关论文
共 50 条
  • [21] Characterization of fetal monocytes in preeclampsia and fetal growth restriction
    Alahakoon, Thushari, I
    Medbury, Heather
    Williams, Helen
    Fewings, Nicole
    Wang, Xin M.
    Lee, Vincent W.
    [J]. JOURNAL OF PERINATAL MEDICINE, 2019, 47 (04) : 434 - 438
  • [22] The diagnosis and management of suspected fetal growth restriction: an evidence-based approach
    Lees, Christoph C.
    Romero, Roberto
    Stampalija, Tamara
    Dall'Asta, Andrea
    DeVore, Greggory R.
    Prefumo, Federico
    Frusca, Tiziana
    Visser, Gerard H. A.
    Hobbins, John C.
    Baschat, Ahmet A.
    Bilardo, Caterina M.
    Galan, Henry L.
    Campbell, Stuart
    Maulik, Dev
    Figueras, Francesc
    Lee, Wesley
    Unterscheider, Julia
    Valensise, Herbert
    Costa, Fabricio Da Silva
    Salomon, Laurent J.
    Poon, Liona C.
    Ferrazzi, Enrico
    Mari, Giancarlo
    Rizzo, Giuseppe
    Kingdom, John C.
    Kiserud, Torvid
    Hecher, Kurt
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (03) : 366 - 378
  • [23] Fetal growth restriction: current knowledge
    Luciano Marcondes Machado Nardozza
    Ana Carolina Rabachini Caetano
    Ana Cristina Perez Zamarian
    Jaqueline Brandão Mazzola
    Carolina Pacheco Silva
    Vivian Macedo Gomes Marçal
    Thalita Frutuoso Lobo
    Alberto Borges Peixoto
    Edward Araujo Júnior
    [J]. Archives of Gynecology and Obstetrics, 2017, 295 : 1061 - 1077
  • [24] Genetic Background of Fetal Growth Restriction
    Nowakowska, Beata Anna
    Pankiewicz, Katarzyna
    Nowacka, Urszula
    Niemiec, Magdalena
    Kozlowski, Szymon
    Issat, Tadeusz
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (01)
  • [25] The Association of Thrombophilia with Fetal Growth Restriction
    Jamal, Ashraf
    Hantoshzadeh, Sedigheh
    Hekmat, Homa
    Abbasi, Shahed
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2010, 13 (06) : 482 - 485
  • [26] Placental pathology in fetal growth restriction
    Vedmedovska, Natalija
    Rezeberga, Dace
    Teibe, Uldis
    Melderis, Ivars
    Donders, Gilbert G. G.
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 155 (01) : 36 - 40
  • [27] Neurodevelopment after Fetal Growth Restriction
    Baschat, Ahmet A.
    [J]. FETAL DIAGNOSIS AND THERAPY, 2014, 36 (02) : 136 - 142
  • [28] Fetal growth restriction: current knowledge
    Machado Nardozza, Luciano Marcondes
    Rabachini Caetano, Ana Carolina
    Perez Zamarian, Ana Cristina
    Mazzola, Jaqueline Brandao
    Silva, Carolina Pacheco
    Gomes Marcal, Vivian Macedo
    Lobo, Thalita Frutuoso
    Peixoto, Alberto Borges
    Araujo Junior, Edward
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 295 (05) : 1061 - 1077
  • [29] Perinatal mortality and fetal growth restriction
    Kady, SM
    Gardosi, J
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2004, 18 (03) : 397 - 410
  • [30] Fetal growth restriction: Pathogenic mechanisms
    Maulik, Dev
    Evans, Jodi Frances
    Ragolia, Louis
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 2006, 49 (02) : 219 - 227